Author | Possas, Cristina | |
Author | Antunes, Adelaide Maria de Souza | |
Author | Oliveira, Alessandra Moreira de | |
Author | Santos, Cristina d’Urso de Souza Mendes | |
Author | Ramos, Mateus Pinheiro | |
Author | Schumacher, Suzanne de Oliveira Rodrigues | |
Author | Homma, Akira | |
Access date | 2024-08-16T16:29:44Z | |
Available date | 2024-08-16T16:29:44Z | |
Document date | 2021 | |
Citation | POSSAS, Cristina et al. Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era. Circular Economy and Sustainability, v. 1, p. 1439-1461, Jul. 2021. | en_US |
ISSN | 2730-597X | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/65402 | |
Language | eng | en_US |
Publisher | Springer | en_US |
Rights | open access | en_US |
Title | Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era | en_US |
Type | Article | en_US |
DOI | 10.1007/s43615-021-00051-y | |
Abstract | In this article, we present breakthroughs and challenges in vaccine development for COVID-19 pandemic, discussing issues related to pandemic preparedness and their implications for circular bioeconomy and sustainability. Notwithstanding the unprecedented accelerated speed of COVID-19 vaccine development, just 9 months after the emergence of the pandemic in Wuhan, China, benefiting from previous developments in SARS and MERS vaccines, significant gaps persist in global vaccine preparedness. These gaps include issues related to immunity and protection, particularly to the limited vaccine protection against recent emergence of concerning new viral variants in the UK, South Africa, and Brazil and the consequent need for vaccine redesign. We examine these gaps and discuss the main issues that could impact on global vaccine availability in the current pandemic scenario: (1) breakthroughs and constraints in development and production of leading global COVID-19 vaccines; (2) innovation and technological development advances and gaps, providing information on global patent assignees for COVID-19, SARS, and MERS vaccine patents; (3) local capacity for development and production of COVID-19, SARS, and MERS vaccines in three emerging agro-based countries (India, Brazil, and South Africa); and (4) future scenarios, examining how these issues and vaccines redesign for new SARS-CoV-2 variants could impact on global access to vaccines and implications for circular bioeconomy and sustainability in the postCOVID era. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Química. Rio de Janeiro, RJ, Brasil / Instituto Nacional da Propriedade Industrial. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Química. Rio de Janeiro, RJ, Brasil / Instituto Nacional da Propriedade Industrial. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Instituto Nacional da Propriedade Industrial. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Química. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Química. Rio de Janeiro, RJ, Brasil. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil. | en_US |
Subject | Vaccine innovation | en_US |
Subject | COVID-19 | en_US |
Subject | SARS | en_US |
Subject | MERS | en_US |
Subject | Pandemic preparedness | en_US |
Subject | Circular economy | en_US |
e-ISSN | 2730-5988 | |
xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |
xmlui.metadata.dc.subject.ods | 12 Consumo e produção responsáveis | |